484 related articles for article (PubMed ID: 25502542)
1. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing.
Valente KN; Lenhoff AM; Lee KH
Biotechnol Bioeng; 2015 Jun; 112(6):1232-42. PubMed ID: 25502542
[TBL] [Abstract][Full Text] [Related]
2. Applications of proteomic methods for CHO host cell protein characterization in biopharmaceutical manufacturing.
Valente KN; Levy NE; Lee KH; Lenhoff AM
Curr Opin Biotechnol; 2018 Oct; 53():144-150. PubMed ID: 29414072
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of host cell protein expression after extended culture and bioreactor production of CHO cell lines.
Hamaker NK; Min L; Lee KH
Biotechnol Bioeng; 2022 Aug; 119(8):2221-2238. PubMed ID: 35508759
[TBL] [Abstract][Full Text] [Related]
6. Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): Implications for downstream process development.
Jin M; Szapiel N; Zhang J; Hickey J; Ghose S
Biotechnol Bioeng; 2010 Feb; 105(2):306-16. PubMed ID: 19739084
[TBL] [Abstract][Full Text] [Related]
7. More similar than different: Host cell protein production using three null CHO cell lines.
Yuk IH; Nishihara J; Walker D; Huang E; Gunawan F; Subramanian J; Pynn AF; Yu XC; Zhu-Shimoni J; Vanderlaan M; Krawitz DC
Biotechnol Bioeng; 2015 Oct; 112(10):2068-83. PubMed ID: 25894672
[TBL] [Abstract][Full Text] [Related]
8. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
Goey CH; Bell D; Kontoravdi C
MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
[TBL] [Abstract][Full Text] [Related]
9. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification.
Levy NE; Valente KN; Lee KH; Lenhoff AM
Biotechnol Bioeng; 2016 Jun; 113(6):1260-72. PubMed ID: 26550778
[TBL] [Abstract][Full Text] [Related]
10. Targeted Capture of Chinese Hamster Ovary Host Cell Proteins: Peptide Ligand Discovery.
Lavoie RA; di Fazio A; Blackburn RK; Goshe MB; Carbonell RG; Menegatti S
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30965558
[TBL] [Abstract][Full Text] [Related]
11. Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).
Farrell A; Mittermayr S; Morrissey B; Mc Loughlin N; Navas Iglesias N; Marison IW; Bones J
Anal Chem; 2015 Sep; 87(18):9186-93. PubMed ID: 26280711
[TBL] [Abstract][Full Text] [Related]
12. The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.
Bracewell DG; Francis R; Smales CM
Biotechnol Bioeng; 2015 Sep; 112(9):1727-37. PubMed ID: 25998019
[TBL] [Abstract][Full Text] [Related]
13. A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies.
Huang L; Wang N; Mitchell CE; Brownlee T; Maple SR; De Felippis MR
Anal Chem; 2017 May; 89(10):5436-5444. PubMed ID: 28414239
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics.
Jawa V; Joubert MK; Zhang Q; Deshpande M; Hapuarachchi S; Hall MP; Flynn GC
AAPS J; 2016 Nov; 18(6):1439-1452. PubMed ID: 27450229
[TBL] [Abstract][Full Text] [Related]
15. Host cell protein dynamics in recombinant CHO cells: impacts from harvest to purification and beyond.
Hogwood CE; Bracewell DG; Smales CM
Bioengineered; 2013; 4(5):288-91. PubMed ID: 23328085
[TBL] [Abstract][Full Text] [Related]
16. Identification of a host cell protein impurity in therapeutic protein, P1.
Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G
J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of host cell protein dynamics in the supernatant of Fc-fusion protein-producing CHO DG44 and DUKX-B11 cell lines in batch and fed-batch cultures.
Park JH; Jin JH; Ji IJ; An HJ; Kim JW; Lee GM
Biotechnol Bioeng; 2017 Oct; 114(10):2267-2278. PubMed ID: 28627725
[TBL] [Abstract][Full Text] [Related]
18. Recovery of Chinese hamster ovary host cell proteins for proteomic analysis.
Valente KN; Schaefer AK; Kempton HR; Lenhoff AM; Lee KH
Biotechnol J; 2014 Jan; 9(1):87-99. PubMed ID: 24039059
[TBL] [Abstract][Full Text] [Related]
19. A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies.
Thomson AS; Mai S; Byrne MP
Biotechnol Bioeng; 2017 Jun; 114(6):1208-1214. PubMed ID: 28112396
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of the CHO host cell protein profile during clarification and protein A capture in a platform antibody purification process.
Hogwood CE; Tait AS; Koloteva-Levine N; Bracewell DG; Smales CM
Biotechnol Bioeng; 2013 Jan; 110(1):240-51. PubMed ID: 22806637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
